These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10913317)
1. Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. Daly NL; Hoffmann R; Otvos L; Craik DJ Biochemistry; 2000 Aug; 39(30):9039-46. PubMed ID: 10913317 [TBL] [Abstract][Full Text] [Related]
2. Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly. Hoffmann R; Dawson NF; Wade JD; Otvös L J Pept Res; 1997 Aug; 50(2):132-42. PubMed ID: 9273897 [TBL] [Abstract][Full Text] [Related]
3. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein. Smet C; Wieruszeski JM; Buée L; Landrieu I; Lippens G FEBS Lett; 2005 Aug; 579(19):4159-64. PubMed ID: 16024016 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and conformational properties of phosphopeptides related to the human tau protein. Du JT; Li YM; Ma QF; Qiang W; Zhao YF; Abe H; Kanazawa K; Qin XR; Aoyagi R; Ishizuka Y; Nemoto T; Nakanishi H Regul Pept; 2005 Aug; 130(1-2):48-56. PubMed ID: 15869817 [TBL] [Abstract][Full Text] [Related]
6. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation. Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747 [TBL] [Abstract][Full Text] [Related]
7. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. Smet C; Sambo AV; Wieruszeski JM; Leroy A; Landrieu I; Buée L; Lippens G Biochemistry; 2004 Feb; 43(7):2032-40. PubMed ID: 14967043 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine- versus serine-phosphorylation leads to conformational changes in a synthetic tau peptide. Fabian H; Otvos L; Szendrei GI; Lang E; Mantsch HH J Biomol Struct Dyn; 1994 Dec; 12(3):573-9. PubMed ID: 7537044 [TBL] [Abstract][Full Text] [Related]
9. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein. Sibille N; Huvent I; Fauquant C; Verdegem D; Amniai L; Leroy A; Wieruszeski JM; Lippens G; Landrieu I Proteins; 2012 Feb; 80(2):454-62. PubMed ID: 22072628 [TBL] [Abstract][Full Text] [Related]
11. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941 [TBL] [Abstract][Full Text] [Related]
12. Ser Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667 [TBL] [Abstract][Full Text] [Related]
13. Nuclear Magnetic Resonance Spectroscopy Insights into Tau Structure in Solution: Impact of Post-translational Modifications. Danis C; Dupré E; Hanoulle X; Landrieu I; Lasorsa A; Neves JF; Schneider R; Smet-Nocca C Adv Exp Med Biol; 2019; 1184():35-45. PubMed ID: 32096026 [TBL] [Abstract][Full Text] [Related]
14. Hyperphosphorylation of tau induces local polyproline II helix. Bielska AA; Zondlo NJ Biochemistry; 2006 May; 45(17):5527-37. PubMed ID: 16634634 [TBL] [Abstract][Full Text] [Related]
16. Distinct functions of cis and trans phosphorylated tau in Alzheimer's disease and their therapeutic implications. Nakamura K; Zhou XZ; Lu KP Curr Mol Med; 2013 Aug; 13(7):1098-109. PubMed ID: 23157676 [TBL] [Abstract][Full Text] [Related]
17. Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro. Yanagawa H; Chung SH; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K Biochemistry; 1998 Feb; 37(7):1979-88. PubMed ID: 9485325 [TBL] [Abstract][Full Text] [Related]
18. Proline Conformation in a Functional Tau Fragment. Ahuja P; Cantrelle FX; Huvent I; Hanoulle X; Lopez J; Smet C; Wieruszeski JM; Landrieu I; Lippens G J Mol Biol; 2016 Jan; 428(1):79-91. PubMed ID: 26655856 [TBL] [Abstract][Full Text] [Related]
19. The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation. Ikura T; Tochio N; Kawasaki R; Matsuzaki M; Narita A; Kikumoto M; Utsunomiya-Tate N; Tate SI; Ito N FEBS Lett; 2018 Sep; 592(18):3082-3091. PubMed ID: 30079475 [TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]